William Kelly
Medical Oncology · Silver Spring, MDNPI 1376781443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for medical oncology clinicians in MD, where the typical reported total is $4,199.
Across 39 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$156
- E.r. Squibb & Sons, L.L.C.$99
- Genentech USA, Inc.$65
- Amgen$58
- AstraZeneca$57
- Bristol Myers Squibb$38
- plus $242 from 11 others
Across 6 payments — averaging $42,761 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$241K
- Exelixis Inc.$15K
What the payments were for
- Food & beverage$716100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $156 |
| E.r. Squibb & Sons, L.L.C. | 5 | $99 |
| Genentech USA, Inc. | 3 | $65 |
| Amgen | 3 | $58 |
| AstraZeneca(2 entities) | 3 | $57 |
| Bristol Myers Squibb | 2 | $38 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $35 |
| Pfizer | 2 | $29 |
| Lilly USA, LLC | 2 | $25 |
| Bayer | 1 | $24 |
| Novartis | 1 | $23 |
| BTG International Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Lexicon Pharmaceuticals, Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Rigel Pharmaceuticals, Inc. | 1 | $17 |
| Merck | 1 | $13 |
How this compares
$716 in reported general payments places this provider in the 35th percentile of 180 medical oncology providers in Maryland.
Other medical oncology in Silver Spring
- Daya SharmaSilver Spring$69K
- Ram TrehanSilver Spring$26K
- Mario EisenbergerBaltimore$2.9M
- Adrian SenderowiczBethesda$1.6M
- Mohit NarangOwing Mills$1.3M
- David SidranskyBaltimore$520K
- Carole MillerBaltimore$331K
- Mark LevisBaltimore$323K
- Tanguy Lim-SeiwertBaltimore$301K
- Shruti ChaturvediBaltimore$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.